Article

In vitro drug testing using patient-derived ovarian cancer organoids

2024-04-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background </bold>Ovarian cancer is the most lethal gynecological cancer. As the primary treatment, chemotherapy has a response rate of only 60–70% in advanced stages, and even lower as a second-line treatment. Despite guideline recommendations, which drugs will be most effective remains unclear. Thus, a strategy to prioritize chemotherapy options is urgently needed. Cancer organo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1290f4b8-57bc-5737-b620-e4b3b90d5866
DOI: 10.21203/rs.3.rs-4307530/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In vitro drug testing using patient-derived ovarian cancer organoidsDOI 10.21203/rs.3.rs-4307530/v1Read

Organoid Models Established from Primary Tumors and Patient-Derived Xenograft Tumors Reflect Platinum Sensitivity of Ovarian Cancer PatientsSemantic proximity Read

Ovarian Cancer Patient-Derived Organoids Used as a Model for Replicating Genetic Characteristics and Testing Drug Responsiveness: A Preliminary Study.Semantic proximity Read

Comprehensive drug efficacy data for mucinous ovarian carcinoma using a novel and extensive biobank of patient-derived organoid modelsSemantic proximity Read

Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responsesSemantic proximity Read

Longitudinal Prediction of Drug Response in High-Grade Serous Ovarian Cancer Organoid Cultures Aligning with Clinical ResponsesSemantic proximity Read

Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testingSemantic proximity Read

Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterationsSemantic proximity Read

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoidsSemantic proximity Read

Exploration of organoids in ovarian cancer: From basic research to clinical translationSemantic proximity Read

Ascites-Derived Organoids for Prediction of Treatment Response and Clinical Management in Ovarian Cancer: A Case ReportSemantic proximity Read

Organoids serve as viable <i>in vitro</i> model for functional precision medicine for mesonephric-like adenocarcinoma of the ovarySemantic proximity Read

A platform for efficient establishment, expansion and drug response profiling of high-grade serous ovarian cancer organoidsSemantic proximity Read